10 ML methylene blue 5 MG/ML Injection [Provayblue] — RxCUI 1788989
RxNorm drug concept · Semantic branded drug
RxCUI 1788989
Semantic branded drug · SBD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1788989
Official name10 ML methylene blue 5 MG/ML Injection [Provayblue]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asProvayblue 50 MG per 10 ML Injection; ProvayBlue 50 MG in 10 ML Injection
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)570 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Methylene Blue: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Methylene blue injection is used to treat a condition called acquired methemoglobinemia — that's when something (like certain chemicals, medications, or toxins) causes a form of he...
- What exactly is methylene blue used for?
- Yes, very likely. Methylene blue is a dye, and about 40% of it passes out of your body through the urine unchanged. Blue or blue-green urine after treatment is expected and not a c...
- Will my urine turn blue after getting this?
🕸️ Concept Web — How 10 ML methylene blue 5 MG/ML Injection [Provaybl... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
10 ML methylene blue 5 MG/ML Injection [Provayblue]
RxCUI 1788989 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Methylene blue
6878IN
-
Methylene blue
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Provayblue
1788985BN
-
Provayblue
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Methylene blue Injection
1737849SCDF -
Methylene blue Injectable Product
1162880SCDG -
Methylene blue Injection [Provayblue]
1788987SBDF -
Provayblue Injectable Product
1788988SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Methylene blue Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
10 ML methylene blue 5 MG/ML Injection
1788984SCD -
Methylene blue 5 MG/ML
1788983SCDC -
Methylene blue 5 MG/ML [Provayblue]
1788986SBDC
-
10 ML methylene blue 5 MG/ML Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
10 ML methylene blue 5 MG/ML Injection
SCD · 1788984 -
Methylene blue 5 MG/ML
SCDC · 1788983 -
Methylene blue Injection
SCDF · 1737849 -
Methylene blue Injectable Product
SCDG · 1162880
Brand-Name Concepts
-
Methylene blue 5 MG/ML [Provayblue]
SBDC · 1788986 -
Methylene blue Injection [Provayblue]
SBDF · 1788987 -
Provayblue Injectable Product
SBDG · 1788988 -
Provayblue
BN · 1788985
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 1788989 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00517-0125-05 | 5 AMPULE in 1 CARTON (0517-0125-05) / 2 mL in 1 AMPULE (051... | PROVAYBLUE | American Regent, Inc. | 2020-04-08 |
| 00517-0371-05 | 5 VIAL, SINGLE-DOSE in 1 CARTON (0517-0371-05) / 2 mL in 1... | PROVAYBLUE | American Regent, Inc. | 2021-12-31 |
| 00517-0374-05 | 5 AMPULE in 1 CARTON (0517-0374-05) / 10 mL in 1 AMPULE (05... | PROVAYBLUE | American Regent, Inc. | 2016-04-08 |
| 00517-0381-05 | 5 VIAL, SINGLE-DOSE in 1 CARTON (0517-0381-05) / 10 mL in 1... | PROVAYBLUE | American Regent, Inc. | 2021-12-31 |
Observed labelers:
American Regent, Inc. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.